Pulmonary Drug Delivery Technologies - A Global Market Perspective

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.MARKET DYNAMICS
Market Overview
Pulmonary Devices: Gaining Pace
Market Highlights
Primary Position of the US
Pulmonary Drug Delivery: An Attractive Non-Invasive Option
Chief Pulmonary Delivery Technologies
Most Effective Route for Respiratory Syndromes
Leading Inhalation Prescription Drugs Across All Segments
The Attractiveness of Inhalers
Choice of Drug Delivery System
Inhalation Therapy: A Retrospection
Pulmonary Drug Delivery - Market Snapshots
3.TRENDS AND ISSUES
Market Snippets
Focus of New Age Pulmonary Devices
Dry Powder Inhalation: A Promising Technology
Research Activities in Inhaled Drug Delivery
Lung Versus Oropharyngeal Deposition: A Major Challenge
Competitive Environment
A Backdrop
Market Leaders
Industry Efforts
Inefficient Use of Pulmonary Drug Delivery Systems
MDIs
Spacers
Dry Powder Inhalers
Issues Facing Various Inhalation Devices
Jet Nebulizers
MDIs
DPIs
4.GROWTH DRIVERS
Growth Drivers in Pulmonary Drug Delivery
Use of Nanotechnology in Drug Delivery Products
Other Growth Areas
Innovative Pulmonary Devices Shape Progress
Pulmonary Insulin
Alternative Drug Delivery Systems: A Review
Market Size
Inhaled Small Molecule Therapeutics
5.PRODUCT FACTS
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Nebulizers
6.REGULATORY ENVIRONMENT
The Montreal Protocol
FDA Bans the Use of CFC’s in Metered Dose Inhalers
7.CORPORATE DEVELOPMENTS
Sepracor Signs Agreement with Nycomed
Kamada Enter into Strategic Pacts with Pari Pharma
GlaxoSmithKline Ties-Up with Amira Pharmaceuticals
Consort Medical Releases Meter Dose Inhalers
Trinity Chiesi Pharmaceuticals Introduces Fostair
BattellePharma Takes Over Ventaira Pharmaceuticals
Eurand Takes Over SourceCF
Aradigm Signs Agreement with Lung Rx forDeveloping AERx Essence(R)- Technology
Vectura Inks Agreement with a European Company
ZYFLO CR™ Obtains FDA Clearance
SkyePharma Revises Agreement with Abott
Alnylam Presents Scientific Progress of ALN-RSV01
Bayer HealthCare and Nektar Therapeutics to Develop NKTR-061
AstraZeneca Launches Symbicort®
Dey, L.P Unveils Perforomist™
Next Safety Rolls Out Hi-Performance Drug Delivery Technology
8.MAJOR PLAYERS
3M Drug Delivery Systems Division (USA)
Akela Pharma Inc (Canada)
Alkermes, Inc. (USA)
Aradigm Corporation (USA)
AstraZeneca Plc (UK)
Baxter Healthcare Corporation (USA)
Chiesi Farmaceutici SpA (Italy)
Consort Medical Plc (UK)
Dey L.P. (USA)
GlaxoSmithKline Plc (UK)
Graceway Pharmaceuticals, LLC (USA)
Nektar Therapeutics (USA)
Oriel Therapeutics, Inc. (USA)
Sepracor, Inc. (USA)
SkyePharma Plc (UK)
Vectura Group Plc (UK)
9.GLOBAL MARKET ANALYTICS
10. THE UNITED STATES
Forecast for the Near Future
Nebulizers: Engraving High Market Interests
New Age Pulmonary Drug Delivery Technologies
Ranking of Inhaled Prescription Drugs in the US
Role of FDA
Metered Dose Inhalers
Non-CFC Metered Dose Inhalers
Dry Powder Inhalers
Popular DPIs in the US
Trends in DPI Devices
Drug Delivery Market in the US
Competitive Landscape
11.CANADA
12.JAPAN
Market Overview
Market Highlights
13.EUROPE
a.France
b.Germany
c.The United Kingdom
d.Italy
e.Spain
f.Russia
g.Rest of Europe
14.ASIA-PACIFIC
China
Market Scenario
India
Market Scenario
Dry Powder Inhalers for Children
Device Prices
Australia
Asthma: The Most Common Chronic Suffering Among Australians
Australia Finding Preventives for Asthma Cure
Use of CFCs in Australia
15.LATIN AMERICA
Brazil
16.REST OF WORLD
Table 1: Percentage Breakdown of Major Brands in the Global Market for Inhaled Drug Delivery Systems –
Table 2: Percentage Breakdown of World Market for Pulmonary Drug Delivery Technologies by Drug Category –
Table 3: Global Pulmonary Drug Delivery Technologies Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Pulmonary Drug Delivery Technologies Market by Region for the Years 2008 & 2009
Table 5: Global Metered Dose Inhalers (MDIs) Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Metered Dose Inhalers (MDIs) Market by Region for the Years 2008 & 2009
Table 7: Global Dry Powder Inhalers (DPIs) Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 8: Percentage Breakdown of Global Dry Powder Inhalers (DPIs) Market by Region for the Years 2008 & 2009
Table 9: Global Nebulizers Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Nebulizers Market by Region for the Years 2008 & 2009
Table 11: Percentage Breakdown of US Market for Pulmonary Drug Delivery Technologies by Application Area – 2010P
Table 12: Percentage Breakdown of the Non-CFC Metered Dose Inhalers Market by Application Areas in the US –
Table 13: Percentage Breakdown of Non-CFC Metered Dose Inhalers Primary Manufacturers in the US –
Table 14: Percentage Breakdown of Leading Dry Powder Inhalers Manufacturers in the US –
Table 15: Percentage Breakdown of Dry Powder Inhalers by Application Areas in the US –
Table 16: Pulmonary Drug Delivery Technologies Market by Product Segment in the US: 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in the US for the Years 2008 & 2009
Table 18: Pulmonary Drug Delivery Technologies Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Canada for the Years 2008 & 2009
Table 20: Percentage Breakdown of Leading Pulmonary Drug Delivery Systems Brands in Japan –
Table 21: Pulmonary Drug Delivery Technologies Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 22: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Japan for the Years 2008 & 2009
Table 23: Pulmonary Drug Delivery Technologies Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 24: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Region in Europe for the Years 2008 & 2009
Table 25: Pulmonary Drug Delivery Technologies Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 26: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Europe for the Years 2008 & 2009
Table 27: Pulmonary Drug Delivery Technologies Market by Product Segment in France: 2007-2015 (Sales in US$ Million)
Table 28: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in France for the Years 2008 & 2009
Table 29: Pulmonary Drug Delivery Technologies Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 30: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Germany for the Years 2008 & 2009
Table 31: Percentage Breakdown of by Major Brands in the UK Market for Inhaled Drug Delivery Systems –
Table 32: Pulmonary Drug Delivery Technologies Market by Product Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in the UK for the Years 2008 & 2009
Table 34: Percentage Breakdown of Major Pulmonary Drug Delivery Systems Brands in Italy –
Table 35: Pulmonary Drug Delivery Technologies Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 36: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Italy for the Years 2008 & 2009
Table 37: Percentage Breakdown of Leading Pulmonary Drug Delivery Systems Brands in Spain –
Table 38: Pulmonary Drug Delivery Technologies Market by Product Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Spain for the Years 2008 & 2009
Table 40: Pulmonary Drug Delivery Technologies Market by Product Segment in Russia: 2007-2015 (Sales in US$ Million)
Table 41: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Russia for the Years 2008 & 2009
Table 42: Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of Europe for the Years 2008 & 2009
Table 44: Pulmonary Drug Delivery Technologies Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
Table 45: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Asia-Pacific for the Years 2008 & 2009
Table 46: Pulmonary Drug Delivery Technologies Market by Product Segment in Latin America: 2007-2015 (Sales in US$ Million)
Table 47: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Latin America for the Years 2008 & 2009
Table 48: Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 49: Percentage Breakdown of Pulmonary Drug Delivery Technologies Market by Product Segment in Rest of World for the Years 2008 & 2009
Companies Profiled